Compare Virgin Galactic Holdings, Inc. (SPCE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Virgin Galactic Holdings, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.7 (market cap $329.06M), while Zimmer Biomet Holdings Inc trades at $89.8 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 52.8× Virgin Galactic Holdings, Inc.'s market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Virgin Galactic Holdings, Inc. pays none. Which is the better fit depends on your goals.
| SPCE | ZBH | |
|---|---|---|
Market Cap | $329.06M | $17.36B |
Sector | Industrials | Health |
52-Week High | $7.52 | $107.71 |
52-Week Low | $2.17 | $79.58 |
Enterprise Value | $428.90M | $24.40B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $2.58, up 0.78% on the day, amid a bearish technical outlook and deeply negative profitability. The company continues to post significant losses, with a net income margin of -19,781.3% in 2025 and negative cash flow from operations. Recent news highlights volatility in the space sector, with SPCE shares reacting to broader industry movements and specific corporate actions like stock awards.
The outlook remains highly speculative, with substantial execution risks and cash burn posing challenges. Investment opportunity hinges on future commercialization success, but current fundamentals and analyst divergence suggest caution. Key risks include reliance on future funding and intense competition in the space tourism sector.
Zimmer Biomet (ZBH) trades at $89.74, down 1.51% on the day, with a bullish technical signal from moving averages and a consensus price target of $97.67. The company reported revenue of $8.23B in 2025, with net income of $705.10M and a net margin of 8.56%. Recent developments include expansion in Asia Pacific and a planned $1 billion share repurchase program, while Q2 2026 earnings are anticipated on August 5, 2026.
ZBH presents a mixed outlook with strong profitability margins and recent earnings beats offset by declining net income margins and rising debt levels. The stock offers potential upside to analyst targets but faces execution risks in competitive medical markets and macroeconomic pressures on healthcare spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
